Kunneman Marleen, Marijnen Corrie A M, Baas-Thijssen Monique C M, van der Linden Yvette M, Rozema Tom, Muller Karin, Geijsen Elisabeth D, Stiggelbout Anne M, Pieterse Arwen H
Leiden University Medical Center, Department of Medical Decision Making, The Netherlands.
Leiden University Medical Center, Department of Radiotherapy, The Netherlands.
Radiother Oncol. 2015 Nov;117(2):338-42. doi: 10.1016/j.radonc.2015.09.005. Epub 2015 Sep 11.
The shared decision making (SDM) model states that patients' values and preferences should be clarified to choose a strategy that best fits the patient. This study aimed to assess whether values and preferences of rectal cancer patients are voiced and considered in deciding about preoperative radiotherapy (PRT), and whether this makes patients feel more involved in treatment decision making.
Pre-treatment consultations of radiation oncologists and patients eligible for PRT were audiotaped (N=90). Tapes were transcribed and coded to identify patients' values and treatment preferences. Patients filled in a post-consultation questionnaire on their perceived involvement in decision making (N=60).
Patients' values were voiced for 62/611 of benefits/harms addressed (10%), in 38/90 consultations (42%; maximum 4 values per consultation), and most often related to major long-term treatment outcomes. Patients' treatment preferences were discussed in 20/90 consultations (22%). In 16/90 consultations (18%), the oncologists explicitly indicated to consider patients' values or preferences. Patients perceived a significantly more active role in decision making if their values or preferences had been voiced or considered.
Patients' values and treatment preferences are voiced or considered in a minority of consultations. If they are, this increases patients' perceived involvement in the decision making process.
共同决策(SDM)模式指出,应明确患者的价值观和偏好,以选择最适合患者的策略。本研究旨在评估直肠癌患者的价值观和偏好在决定是否进行术前放疗(PRT)时是否得到表达和考虑,以及这是否会让患者感觉更多地参与到治疗决策中。
对符合PRT条件的放疗肿瘤学家与患者的治疗前咨询进行录音(N = 90)。对录音进行转录和编码,以确定患者的价值观和治疗偏好。患者填写一份关于他们在决策中参与感的咨询后问卷(N = 60)。
在讨论的611项获益/危害中,有62项(10%)提到了患者的价值观,在90次咨询中有38次(42%;每次咨询最多提及4项价值观),且大多与主要的长期治疗结果相关。在90次咨询中有20次(22%)讨论了患者的治疗偏好。在90次咨询中有16次(18%),肿瘤学家明确表示会考虑患者的价值观或偏好。如果患者的价值观或偏好得到表达或考虑,他们会感觉在决策中发挥了更积极的作用。
在少数咨询中会提及患者的价值观和治疗偏好。如果提及了,这会增加患者在决策过程中的参与感。